We are live on ! Find out more
CP

CenterBook Partners Portfolio holdings

AUM $1.86B
1-Year Est. Return 24.52%
This Fund
S&P 500
This Quarter Est. Return
+11.36%
1 Year Est. Return
+24.52%
3 Year Est. Return
+37.52%
5 Year Est. Return
10 Year Est. Return
AUM
$2.02B
AUM Growth
+$224M
Cap. Flow
+$117M
Cap. Flow %
5.76%
Top 10 Hldgs %
15.73%
Holding
685
New
192
Increased
180
Reduced
172
Closed
141

Top Buys

Rank Stock Value
1
AMD icon
Advanced Micro Devices
AMD
+$28.1M
2
TXN icon
Texas Instruments
TXN
+$27.5M
3
SNOW icon
Snowflake
SNOW
+$21.9M
4
COST icon
Costco
COST
+$18.5M
5
DLTR icon
Dollar Tree
DLTR
+$15.9M

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$26.8M
2
HOOD icon
Robinhood
HOOD
+$19.8M
3
AVGO icon
Broadcom
AVGO
+$18.3M
4
MCD icon
McDonald's
MCD
+$16.4M
5
EVLV icon
Evolv Technologies
EVLV
+$14.1M

Sector Composition

Rank Sector Weight
1 Technology 24.32%
2 Healthcare 15.99%
3 Industrials 12.29%
4 Consumer Discretionary 10.73%
5 Financials 10.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HAE icon
526
Haemonetics
HAE
$3.89B
$324K 0.02%
+6,650
New +$412K
INTU icon
527
Intuit
INTU
$86.5B
$304K 0.02%
445
-2,260
-84% -$1.63M
EXPE icon
528
Expedia Group
EXPE
$35.4B
$297K 0.01%
1,389
-15,366
-92% -$3.09M
ICHR icon
529
Ichor Holdings
ICHR
$2.62B
$263K 0.01%
+15,037
New +$286K
RIO icon
530
Rio Tinto
RIO
$158B
$256K 0.01%
3,871
-290
-7% -$17.9K
PRGS icon
531
Progress Software
PRGS
$1.66B
$247K 0.01%
+5,612
New +$259K
BAP icon
532
Credicorp
BAP
$31.8B
$242K 0.01%
+908
New +$225K
ACAD icon
533
Acadia Pharmaceuticals
ACAD
$4.43B
$238K 0.01%
+11,152
New +$264K
TTWO icon
534
Take-Two Interactive
TTWO
$45.4B
$237K 0.01%
916
-15,574
-94% -$3.69M
SYK icon
535
Stryker
SYK
$125B
$236K 0.01%
+639
New +$247K
CPRX
536
DELISTED
Catalyst Pharmaceutical
CPRX
$235K 0.01%
11,908
-3,031
-20% -$62.3K
LAD icon
537
Lithia Motors
LAD
$8.47B
$232K 0.01%
733
-881
-55% -$284K
LXU icon
538
LSB Industries
LXU
$783M
$231K 0.01%
29,340
-226,845
-89% -$1.84M
KEX icon
539
Kirby Corp
KEX
$7.01B
$227K 0.01%
+2,719
New +$273K
VVX icon
540
V2X
VVX
$2.83B
$214K 0.01%
+3,686
New +$197K
DE icon
541
Deere & Co
DE
$160B
$201K 0.01%
+440
New +$217K
SBRA icon
542
Sabra Healthcare REIT
SBRA
$5.34B
$192K 0.01%
+10,283
New +$192K
FINV
543
FinVolution Group
FINV
$1.15B
$164K 0.01%
22,191
-118,095
-84% -$1.04M
EWCZ
544
DELISTED
European Wax Center
EWCZ
$140K 0.01%
35,161
-779,010
-96% -$3.56M
ABEV icon
545
Ambev
ABEV
$48.1B
-11,169
Closed -$26.9K
ACHR icon
546
Archer Aviation
ACHR
$3.54B
-41,772
Closed -$453K
ACIW icon
547
ACI Worldwide
ACIW
$5.83B
-15,181
Closed -$697K
ADMA icon
548
ADMA Biologics
ADMA
$1.96B
-87,721
Closed -$1.6M
AGCO icon
549
AGCO
AGCO
$7.15B
-31,376
Closed -$3.24M
AGIO icon
550
Agios Pharmaceuticals
AGIO
$1.79B
-243,063
Closed -$8.08M

Similar funds

CenterBook Partners's Q3 2025 Portfolio in Review

As of Q3 2025, CenterBook Partners held 685 positions worth $2.02B, up 12% from $1.8B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

CenterBook Partners deployed $117M of net new capital in Q3 2025, opening 192 new positions and adding to 180 existing holdings. Its largest new stake was Kyivstar Group: 860,569 shares worth $10.8M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Evolv Technologies, an estimated $14.1M trimmed.

  • CenterBook Partners's largest Q3 2025 buy was Kyivstar Group: 860,569 shares worth $10.8M.
  • CenterBook Partners added most to Advanced Micro Devices in Q3 2025, an estimated $28.1M increase.
  • CenterBook Partners's biggest Q3 2025 reduction was Evolv Technologies, cutting an estimated $14.1M.
  • CenterBook Partners fully exited Eli Lilly in Q3 2025, selling an estimated $26.8M.
  • CenterBook Partners's ten largest holdings make up 16% of its $2.02B portfolio in Q3 2025.
  • CenterBook Partners opened 192 new positions and closed 141 in Q3 2025.
  • CenterBook Partners's portfolio value rose 12% quarter-over-quarter to $2.02B.

Based on CenterBook Partners's 13F filing for Q3 2025, filed 7 Nov 2025.